 "Cipla, Cipla logo, Cipla headquarters")
Drug major Cipla on Friday posted a marginal decline in its consolidated net profit to Rs 706 crore for the first quarter ended June 30, 2022.
The Mumbai-based company had reported a net profit of Rs 710 crore in the April-June quarter of the last fiscal.
Total revenue from operations declined to Rs 5,375 crore in the June quarter as compared with Rs 5,504 crore in the year-ago period, Cipla said in a regulatory filing.
Shares of the company ended 1.08 per cent up at Rs 978.15 apiece on the BSE.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
